Back

Association of LDL-C/ApoB ratio with pathogenic variants in familial hypercholesterolemia

28 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Lipid lowering (1) Drug therapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Felix Wollmann

AKH, Wien (Austria)

6 More presentations in this session

Presentation thumbnail
Bridging the gap: real-world eligibility for lipoprotein(a)-targeted therapies in chronic and acute coronary syndrome
Doctor E. Steinacher (Vienna, AT)
Abstract Slides
Presentation thumbnail
LDL-C target achievement does not equal risk resolution after ACS: residual atherogenic and inflammatory burden despite maximal oral triple lipid therapy
Doctor K. Mahajan (Mandi, IN)
Abstract Slides
Presentation thumbnail
Real-world efficacy and tolerability of lipid-lowering therapy in children with monogenic familial hypercholesterolemia in primary care
Mr R. Schmieder (Munich, DE)
Abstract Slides
Presentation thumbnail
Association of apolipoprotein B and lipoprotein(a) with severe atherosclerotic cardiovascular disease in patients with acute coronary syndrome: the modifying effect of prior lipid-lowering therapy.
Mr A. Meseguer Hernandez (Cartagena, ES)
Abstract Slides
Presentation thumbnail
Elective coronary revascularisation represents an unutilised opportunity to optimise lipid management: results from a multicentre observational cohort
Miss M. van den Bogaart (Amsterdam, NL)
Abstract Slides

Access the full session

Session thumbnail
Lipid lowering (1)

The Event

Event poster

ESC Congress 2026

28 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Discordance between LDL cholesterol and apolypoprotein B. Which to prefer to guide treatment?
13 April 2023
thumbnail
Congress Presentation
Feasibility study to boost ascertainment of FH in diverse primary care populations using FAMCAT tool and pharmacist review
30 August 2024
thumbnail
Congress Presentation
Plasma lipids and risk of aortic valve stenosis: A Mendelian randomization study
28 August 2020
thumbnail
Congress Presentation
RNA interference targeting apolipoprotein C-III with ARO-APOC3 in healthy volunteers mimics lipid and lipoprotein findings seen in subjects with inherited apolipoprotein C-III deficiency
31 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources